Chris Waddick is a Chief Financial Officer at Cardiol Therapeutics. They possess expertise in mergers and acquisitions, strategy, start ups, due diligence, financial reporting and 11 more skills. Colleagues describe them as "Chris and I have recently been working together to develop the long term business strategies for a start up company that is focused on the consolidation of a highly fragmented business within the medical devices industry sector. Chris has demonstrated his natural leadership during the planning stages of this early phase company. I have found Chris to be a mentor, a business advisor and a strategic thinker with comprehensive corporate finance, P& L, and corporate governance… Show more" and "I had the great opportunity to work with Chris over a many years on a number of financing and M&A transactions for Vasogen. He showed great leadership throughout, tenacious in the pursuit of Vasogen's business goals and with terrific sense of humour and timing. Chris has real talent for organizing, managing and inspiring a broad team of people - employeees, board members, service providers and others."